FdaApplication
NDA 211913
Identifiers
- fda_app_no: NDA211913
Properties
| Property | Value |
|---|---|
| applicant_name | SUN PHARMACEUTICAL INDUSTRIES LTD |
| application_type | NDA |
| approval_date | 2019-11-05 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ABSORICA LD | ISOTRETINOIN | 32MG | CAPSULE;ORAL |
| ABSORICA LD | ISOTRETINOIN | 24MG | CAPSULE;ORAL |
| ABSORICA LD | ISOTRETINOIN | 28MG | CAPSULE;ORAL |
| ABSORICA LD | ISOTRETINOIN | 16MG | CAPSULE;ORAL |
| ABSORICA LD | ISOTRETINOIN | 8MG | CAPSULE;ORAL |
| ABSORICA LD | ISOTRETINOIN | 20MG | CAPSULE;ORAL |
6 products